INSIGHTS ON DRUG DEVELOPMENT

• The High Intensity Sweeteners Neotame And Sucralose

  Learn how high-intensity sweeteners can mask bitter aftertastes and support patient adherence, with practical guidance on stability, safety, dosage-form applications, and market perception.

• Patented Process For Intermediates Useful For Etrasimod Arginine

  Explore how rethinking the synthetic strategy for Etrasimod can overcome the limitations of legacy routes, enabling more efficient chirality control, improved scalability, and more practical industrial API production.

• Managing The Challenges Of Controlled Substance Manufacturing

  How can manufacturers balance security, compliance, and supply continuity in controlled substance development and production?

• ADC Development Grows More Complex — SPR Insights Bring Clarity

  Explore how real-time kinetic analysis reveals how conjugation, linker chemistry, and drug loading influence antibody–antigen interactions, while enabling sensitive detection of anti-drug antibodies.

• Advantages Of Spray-Dried Mannitol In Roll Compaction

  4/2/2025

  Pharmaceutical excipients like mannitol enhance formulation stability, flowability, and compressibility, which are crucial for robust tablets. Read how these properties improve patient compliance.

• Particles In High Concentration Biotherapeutics

  8/7/2025

  Examine advanced analytical solutions that detect, characterize, and mitigate particle formation in high-concentration biotherapeutics caused by protein aggregation and surfactant degradation.

• An Integrated Analytical Approach To Lipase Risk Management In Biologics Development

  9/8/2026

  Conventional HCP testing cannot confirm whether residual lipases remain enzymatically active. Here, the authors examine why functional activity data are essential for managing polysorbate-related stability risk in biologics development.

• Comprehensive And Streamlined Genomic Signature Assessment

  6/9/2026

  Simultaneous analysis of HRD, TMB, and MSI offers a more complete view of tumor biology. A modular sequencing approach enables efficient workflows, conserves samples, and delivers deeper insights.

• A Patented Process For Intermediates Useful For Upadacitinib

  2/18/2026

  Discover how innovative and safer synthetic strategies can streamline the manufacture of Upadacitinib while addressing the complexity and safety challenges inherent in its key intermediates.